The Laboratory Animal Model Market in North America is gaining momentum as biotechnology companies, pharmaceutical manufacturers, and academic research centers strengthen their focus on advanced biomedical research and drug development.

Market Overview

The Laboratory Animal Model market was valued at US$ 1.6 billion in 2025 and is expected to reach US$ 2.97 billion by 2034; it is estimated to record a CAGR of 7.11% during 2026-2034.Laboratory animal models are used to study biological processes, understand disease mechanisms, evaluate drug safety, and assess the effectiveness of potential treatments. Commonly used models include mice, rats, rabbits, zebrafish, guinea pigs, and other species selected according to specific research requirements.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00025691

Increasing Demand for Preclinical Research

The growing need for reliable preclinical research is supporting demand for laboratory animal models. Pharmaceutical and biotechnology companies use these models to evaluate the safety, toxicity, pharmacological activity, and potential therapeutic effects of drug candidates before clinical trials. Increasing research into cancer, neurological disorders, cardiovascular diseases, metabolic conditions, and infectious diseases is encouraging the use of specialized animal models across biomedical research.

Market Growth Drivers

Expansion of pharmaceutical research and development is a major factor influencing the laboratory animal model industry. Increasing investments in drug discovery, vaccine development, gene therapy, and personalized medicine are creating demand for suitable research models. Academic research programs and government-funded scientific initiatives are also supporting the use of laboratory animals to investigate complex biological processes and disease pathways.

Advancements in Genetically Modified Animal Models

Technological developments in genetic engineering are transforming laboratory animal research. Genetically modified models, including knockout, knock-in, and transgenic animals, help researchers investigate specific genes and understand their role in disease development. Advanced gene-editing technologies are supporting the development of more targeted research models for studying genetic disorders, cancer, and other complex conditions.

Laboratory Animal Model Market Growth 

The expansion of drug discovery and preclinical testing is creating opportunities for laboratory animal model providers. Researchers use animal models to examine drug responses, identify potential safety concerns, and understand therapeutic mechanisms. Increasing development of biologics, vaccines, and advanced therapies is encouraging demand for specialized models that can support different stages of pharmaceutical research.

Rising Focus on Personalized Medicine

The growing emphasis on personalized medicine is influencing the development and application of laboratory animal models. Humanized animal models and genetically engineered systems can help researchers investigate human-specific biological responses and evaluate potential treatments. These models are particularly relevant to research involving immunology, oncology, infectious diseases, and gene-based therapies. Continued advances in biomedical research are supporting demand for more specialized and disease-specific models.

Increasing Emphasis on Animal Welfare and Ethical Research

Animal welfare and ethical research practices are important considerations in the laboratory animal model industry. Research institutions and pharmaceutical companies follow regulatory guidelines and institutional review procedures to ensure responsible animal care and use. The principles of replacement, reduction, and refinement (3Rs) encourage researchers to replace animal testing where suitable alternatives exist, reduce the number of animals used, and refine procedures to minimize discomfort. These practices are influencing laboratory operations and research planning.

Role of Alternative Research Technologies

Developments in organ-on-chip systems, cell-based assays, computational modeling, and three-dimensional tissue cultures are creating additional approaches for biomedical research. Although these technologies can complement or replace certain animal studies, laboratory animal models continue to play a role in evaluating complex biological interactions and whole-organism responses. Research organizations are increasingly exploring integrated approaches that combine animal models with alternative testing technologies.

Regional Growth Opportunities

The adoption of laboratory animal models varies across regions according to pharmaceutical research activity, biotechnology investments, academic capabilities, and regulatory frameworks. Established research markets benefit from advanced laboratory infrastructure and strong pharmaceutical development activities. Meanwhile, emerging economies are expanding biotechnology research, academic laboratories, and preclinical testing capabilities, creating opportunities for laboratory animal model providers.

Key Players

• Charles River Laboratories International, Inc.

• Envigo

• Eurofins Scientific

• genOway

• Hera Biolabs

• JSR Life Sciences, LLC (Crown Bioscience International)

• Ozgene Pty Ltd.

• PerkinElmer (Horizon Discovery Ltd.)

• Taconic Biosciences, Inc.

Future Outlook

The laboratory animal model industry is expected to evolve as pharmaceutical research, genetic engineering, and biomedical innovation continue to advance. Growing demand for specialized models, increasing development of advanced therapies, and continued investment in preclinical research are likely to influence industry development. At the same time, ethical research practices and alternative testing technologies will shape how animal models are selected and used in scientific investigations.

Related Reports

Hirsutism Treatment Market Trends, Size & Growth by 2034

HIV Self Test Kits Market Demand, Share & Growth by 2034

About Us

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us

Contact Person: Ankit Mathur
E-mail:ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish